動態

• 

  Mary Grace N. Tamio   shared news

  在 August 08 2024 at 09:50 PM 已編輯 public

  Gut resistome of NSCLC patients treated with immunotherapy
  
  #gutresistome #immunotherapy #journals #articles
  
  Mors info | ⬇️

  

  Gut resistome of NSCLC patients treated with immunotherapy

  BackgroundThe newest method of treatment for patients with NSCLC (non-small cell lung cancer) is immunotherapy directed at...
  0 0 0 0 0 0 0

  comment 留言

  thumb_upLike

  share 分享
• 

  Mary Grace N. Tamio   shared news

  在 May 26 2024 at 08:30 PM 已編輯 public

  SLC7A5 correlated with malignancies and immunotherapy response in bladder cancer
  
  #immunotherapy #bladdercancer #journals #articles
  
  More info | ⬇️

  

  SLC7A5 correlated with malignancies and immunotherapy response in bladder cancer

  Metabolic reprogramming contributes to bladder cancer development. This study aimed to understand the role of SLC7A5 in bl...
  0 0 0 0 0 0 0

  comment 留言

  thumb_upLike

  share 分享
• 

  Mary Grace N. Tamio   shared news

  在 May 07 2024 at 09:13 PM 已編輯 public

  Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer
  
  #breastcancer #tumor #immunotherapy #drugresistance #journals #articles
  
  More info | ⬇️

  

  Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer

  Breast cancer, the most frequent female malignancy, is often curable when detected at an early stage. The treatment of met...
  0 0 0 0 0 0 0

  comment 留言

  thumb_upLike

  share 分享
• 

  Mary Grace N. Tamio   shared news

  在 January 31 2024 at 08:43 PM 已編輯 public

  Unlocking the ‘ova’-coming power: immunotherapy’s role in shaping the future of ovarian cancer treatment
  
  #immunotherapy #cancer #ovariancancer #journals #articles
  
  More info | ⬇️

  

  Unlocking the ‘ova’-coming power: immunotherapy’s role in shaping the future of ovarian cancer treatment

  Ovarian cancer is a prominent cancer worldwide with a relatively low survival rate for women diagnosed. Many individuals a...
  0 0 0 0 0 0 0

  comment 留言

  thumb_upLike

  share 分享
• 

  Mary Grace N. Tamio   shared news

  在 January 11 2024 at 10:23 PM 已編輯 public

  Integrated immunogenomic analyses of high-grade serous ovarian cancer reveal vulnerability to combination immunotherapy
  
  #ovariancancer #immunotherapy #journals #articles
  
  More info | ⬇️

  

  Integrated immunogenomic analyses of high-grade serous ovarian cancer reveal vulnerability to combination immunotherapy

  medRxiv - The Preprint Server for Health Sciences
  0 0 0 0 0 0 0

  comment 留言

  thumb_upLike

  share 分享